Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes

ImmunoHorizons
doi 10.4049/immunohorizons.1900014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus

PLoS ONE
Multidisciplinary
2014English

Development of Postpartum Graves’ Disease and Type 1 Diabetes After Delivery in a Patient With Gestational Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2010English

Antigen Specific Treatment for the Inhibition and Remission of Type 1 Diabetes

Japanese Journal of Clinical Immunology
2008English

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Antibody-Mediated Oral Delivery of Therapeutic DNA for Type 2 Diabetes Mellitus

Biomaterials Research
MedicineBiomaterialsCompositesBiomedical EngineeringCeramics
2018English

P088 Characterization of Novel Humanized IL-17 Mouse Preclinical Platforms for the Efficacy Evaluation of Anti-Human IL17 Therapeutics

2019English

Prospects of Antigen-Specific Therapy in Type 1 Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

RALA-mediated Delivery of FKBPL Nucleic Acid Therapeutics

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2015English

Erratum To: CX3CR1 Deficiency Accelerates the Development of Retinopathy in a Rodent Model of Type 1 Diabetes

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy